InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the detailed record of transactions filed by Schmidt Donal Ray Jr., Chairman & CEO. Officer active across 1 company, notably Rapid Therapeutic Science Laboratories, Inc.. In total, 1 disclosures have been logged. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Donal Ray Schmidt Jr. is the Chief Executive Officer of Rapid Therapeutic Science Laboratories, Inc. He is responsible for the strategic direction of the company, which focuses on developing innovative therapeutic solutions.